A phase II study of daily carboplatin plus irradiation followed by durvalumab therapy for older adults (≥75 years) with unresectable III non-small-cell lung cancer and performance status of 2: NEJ039A
一项针对老年(≥75岁)不可切除的III期非小细胞肺癌且体能状态评分为2分患者的II期研究:NEJ039A
期刊:ESMO Open
影响因子:8.3
doi:10.1016/j.esmoop.2024.103939
Mouri, A; Kisohara, A; Morita, R; Ko, R; Nakagawa, T; Makiguchi, T; Isobe, K; Ishikawa, N; Kondo, T; Akiyama, M; Bessho, A; Honda, R; Yoshimura, K; Kagamu, H; Kato, S; Kobayashi, K; Kaira, K; Maemondo, M